
UNC0379 trifluoroacetate
CAS No. 1620401-83-3
UNC0379 trifluoroacetate( UNC-0379 trifluoroacetate )
Catalog No. M12380 CAS No. 1620401-83-3
UNC0379 is a selective, +N2106:AC2106substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 118 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUNC0379 trifluoroacetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC0379 is a selective, +N2106:AC2106substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM.
-
DescriptionUNC0379 is a selective, +N2106:AC2106substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM, displays good selectivity over 15 other methyltransferases, including G9a and GLP (IC50>100 uM); causes neuroblastoma (NB) cell growth inhibition which is p53 dependent, reduces levels of p53K382me1 modification in xenografts.
-
In VitroUNC0379 TFA (1-10 μM, 9 days) inhibits HGSOC cells proliferation.UNC0379 TFA (10 μM, 96 h) increases in the proportion of sub-G1 phase cells in HGSOC cells.UNC0379 TFA (10 μM, 48 h) induces myofibroblast de-differentiation and inhibits additional fibroblast to myofibroblast differentiation. Cell Viability Assay Cell Line:JHOS2, JHOS3, JHOS4, OVCAR3, OVCAHO, OVKATE, KURAMOCHI, TYKnu Concentration:1-10 μM Incubation Time:9 days Result:Inhibited HGSOC cells proliferation with IC50s ranging from 0.39 to 3.20 μM.Cell Cycle Analysis Cell Line:JHOS3, OVCAR3 Concentration:10 μM Incubation Time:96 h Result:Arrested cells in sub-G1 phase.
-
In VivoUNC0379 TFA (intratracheal administration, 1 mg/kg/day, 1 mg/kg/day, on day7, 8, and 9) ameliorates the lung fibrosis in Bleomycin (BLM)-induced lung fibrosis mouse. Animal Model:Bleomycin (BLM)-induced lung fibrosis mouse modelDosage:1 mg/kg/day Administration:Intratracheal administration, on day7, 8, and 9.Result:Ameliorated BLM-induced lung fibrosis (supported by the evaluation of the Ashcroft score and changes in the collagen content in the lung samples) without affecting pulmonary inflammation.
-
SynonymsUNC-0379 trifluoroacetate
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1620401-83-3
-
Formula Weight527.5797
-
Molecular FormulaC25H36F3N5O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOC1=CC2=NC(N3CCCC3)=NC(NCCCCCN4CCCC4)=C2C=C1OC.O=C(O)C(F)(F)F
-
Chemical Name4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-, 2,2,2-trifluoroacetate (1:x)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ma A, et al. J Med Chem. 2014 Aug 14;57(15):6822-33.
2. Ma A, et al. Medchemcomm. 2014 Dec;5(12):1892-1898.
3. Veschi V, et al. Cancer Cell. 2017 Jan 9;31(1):50-63.
molnova catalog



related products
-
UNC0224
A potent, selective G9a/GLP inhibitor with IC50 of 57 nM and 58 nM CLOT biochemical assays.
-
PFI-2 hydrochloride
A first-in-class, potent and selective inhibitor of SETD7 methyltransferase with Ki app/IC50 of 0.33/2 nM.
-
AZ505
AZ505 (AZ-505, AZ 505) is a potent and selective inhibitor of protein lysine methyltransferase SMYD2 with IC50 of 0.12 uM.